The US Food and Drug Administration (FDA) on Monday finalized guidance to pharmaceutical and biotech sponsors looking for more advice on when non-inferiority studies demonstrating effectiveness of an ...
Protocol fidelity and transparency about changes are essential to the credibility of randomised controlled trials In recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results